Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Plectranthus diterpenes as a potential anticancer and antitubercular combined system
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-039-Monday
- By: SILVA, Henrique (CBIOS/ULHT, Lisboa, Portugal)
- Co-author(s): Catarina Garcia: CBIOS, Universidade Lusófona, Lisboa, Portugal
Joana Marçalo: CBIOS, Universidade Lusófona, Lisboa, Portugal
Henrique Silva: CBIOS, Universidade Lusófona, Lisboa, Portugal
Marisa Nicolai: CBIOS, Universidade Lusófona, Lisboa, Portugal
Epole Ntungwe: CBIOS, Universidade Lusófona, Lisboa, Portugal
Catarina Silva: CBIOS, Universidade Lusófona, Lisboa, Portugal
Milica Pesik: Institute for Biological Research, “Siniša Stanković“, University of Belgrade, Belgrade, Serbia
Tijana Stankovic: Institute for Biological Research, “Siniša Stanković“, University of Belgrade, Belgrade, Serbia
Catarina Reis: CBIOS, Universidade Lusófona, Lisboa, Portugal
Gian Maria Fimia: Laboratorio di Biologia Cellulare e Microscopia Elettronica, National Institute for the Infectious Disease Lazzaro Spallanzani, Rome, Italy
Célia Faustino: iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Lisboa, Portugal
Carlos A. M. Afonso: iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Lisboa, Portugal
Luís M. Rodrigues: CBIOS, Universidade Lusófona, Lisboa, Portugal
Patrícia Rijo: CBIOS, Universidade Lusófona, Lisboa, Portugal;iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Lisboa, Portugal - Abstract:
Backgrounds
Medicinal plants such as Plectranthus spp. represent a source of lead natural products. Previously, some halimane derivatives (P. ornatus Benth.), structurally similar to Rv3377c and Rv3378c targets (important to Mycobacterium tuberculosis survival and virulence) were prepared and the cytotoxic agent 6,7-dehydroroyleanone was isolated
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023